Fortrea Holdings (FTRE) Current Deferred Revenue (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Current Deferred Revenue came in at $502.7 million in Q2 2026, up 16656.67% on a YoY basis from N/an in Q2 2025, and up 4.45% quarter-over-quarter from $481.3 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Current Deferred Revenue for 5 consecutive years, with $502.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Deferred Revenue rose 16656.67% year-over-year to $502.7 million; the trailing twelve-month figure through Jun 2026 stood at $502.7 million (up 16656.67% YoY), and the FY2025 full-year result was $473.8 million, up 34.11% from the prior year.
- Current Deferred Revenue grew to $502.7 million in Q2 2026 per FTRE's latest filing, from $481.3 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $502.7 million in Q2 2026 and bottomed at $3.0 million in Q1 2025.
- Historically, Current Deferred Revenue has averaged $289.2 million across 5 years, with a median of $268.2 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue slumped 98.79% in 2025, then soared 16656.67% in 2026.
- Over 5 years, Current Deferred Revenue stood at $271.5 million in 2022, then declined by 21.1% to $214.2 million in 2023, then jumped by 64.94% to $353.3 million in 2024, then jumped by 34.11% to $473.8 million in 2025, then rose by 6.1% to $502.7 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $502.7 million, $481.3 million, and $473.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 502.70 Mn |
| Mar 31, 2026 | 481.30 Mn |
| Dec 31, 2025 | 473.80 Mn |
| Sep 30, 2025 | 411.60 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 353.30 Mn |
| Sep 30, 2024 | 321.10 Mn |
| Jun 30, 2024 | 248.00 Mn |
| Mar 31, 2024 | 236.90 Mn |
| Dec 31, 2023 | 214.20 Mn |
| Sep 30, 2023 | 264.80 Mn |
| Jun 30, 2023 | 264.30 Mn |
| Dec 31, 2022 | 271.50 Mn |